ClinicalTrials.Veeva

Menu

Functional Interest of Non Invasive Brain Stimulation During Physiotherapy at a Subacute Phase Post Stroke (Anodal Protocol): ReSTIM

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Stroke

Treatments

Device: anodal tDCS (device) Eldith DC-Stimulator
Device: Sham tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT01500564
2010.635

Details and patient eligibility

About

Previous research that utilises single sessions of transcranial direct current stimulation (tDCS) have demonstrated functional improvements. However these improvements are usually short-lived, lasting less than one hour before the patient's performance returns to baseline. In these studies, tDCS is typically applied with the goal of adaptively enhancing functional activation of pathologically under-active tissue or suppressing pathologically over-active tissue. Interestingly, a small body of evidence is now emerging to indicate that tDCS can improve learning/memory functions in healthy controls. The goal of this study is to test if the application of tDCS could enhance learning and/or memory for physiotherapy rehabilitation, which may in turn lead to correspondingly greater motor improvement. Patients at a subacute stage (1 to 6 month post stroke) will attend for 10 consecutive daily sessions of tDCS.

This research has important implications; previous studies suggest that such an approach has the potential to facilitate physical rehabilitation post-stroke and establish tDCS as a clinically viable rehabilitative tool. Recovery of motor skills may take many months to acquire and therefore strategies that have the potential to enhance acquisition of skill are of practical and scientific interest.

Enrollment

10 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All subjects must be between the ages of 18-90 and must not be pregnant.
  • Patients volunteer to participate in the study, with a written informed consent signed
  • Affiliation to a national health insurance program
  • First-time clinical ischemic or hemorrhagic cerebrovascular accident - evidenced by a radiological (or physician's) report
  • Contralesional motor deficit
  • Lesion sparing primary motor cortex
  • Stroke onset >1 month and <6 months prior to study enrollment

Exclusion criteria

  • Coexistent major neurological or psychiatric disease as to decrease number of confounders
  • History of epilepsy before stroke (or episodes of seizures within the last six months)
  • Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing
  • Subjects with global aphasia and deficits of comprehension
  • Excessive pain in any joint of the paretic extremity (VAS>4)
  • Contraindications to Tdcs : metal in the head, implanted brain medical devices
  • Coexistent major neurological or psychiatric disease as to decrease number of confounders
  • A history of significant alcohol or drug abuse in the prior 6 months
  • Anyone who is currently taking or who has taken anti-malarial treatment in the last 72 hours
  • Subjects may not have already received constraint induced motor therapy and/or tDCS treatment for stroke
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

10 participants in 2 patient groups

Sham tDCS and motor training: sham comparator
Sham Comparator group
Description:
Participants will receive sham tDCS over the primary motor cortex of the ipsilesional hemisphere during 20 minutes of motor training (10 consecutive sessions Monday-Friday during two weeks). Intervention: placebo tDCS Other: Motor Training
Treatment:
Device: Sham tDCS
Anodal tDCS and motor training: experimental
Experimental group
Description:
Participants will receive anodal tDCS over the primary motor cortex of the ipsilesional hemisphere. The following parameters will be used: stimulation intensity of 1mA during 20 minutes of motor training (10 consecutive sessions Monday-Friday during two weeks). Interventions: * Device: anodal tDCS * Other: motor Training during physiotherapy
Treatment:
Device: anodal tDCS (device) Eldith DC-Stimulator

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems